Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial

Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients who had not responded to or had relapsed after...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mario G. Pessôa, Hugo Cheinquer, Paulo R.L. Almeida, Giovanni F. Silva, Maria Patelli J.S. Lima, Raymundo Paraná, Marco A. Lacerda, Edison R. Parise, José R.B. Pernambuco, Suelene S. Pedrosa, Rosângela Teixeira, Hoel Sette, Jr, Fernando Tatsch
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2012-01-01
Edice:	Annals of Hepatology
Témata:	Hepatitis C Re-treatment Peginterferon alfa-2a (40KD) Amantadine
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S1665268119314863
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!